Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Apply expense trends to adjust your budget, making proactive changes that reflect shifting costs and priorities.
22,036 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
When a stock climbs 250% in a year, funds often trim positions to lock in gains and manage risk. This article explain...
Cathie Wood is known for bold bets, but recently her moves hint at bargain-hunting in big-name tech. This article bre...
Bitcoin is sliding off its all-time highs in what many call this bitcoin's shallowest bear. Learn what that means, wh...
A 63-year-old couple converting $90,000 to a Roth in 2026 could face higher Medicare premiums in 2028 due to the IRMA...
On Tuesday, Broadcom shifted higher as investors rotated into hardware names and welcomed a positive analyst update. ...
Honor Warren turning 18 marks more than a birthday—it signals a real-life classroom on college planning. This guide t...
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
Two niche AI players, one high-stakes market. This in-depth guide explains what investors should know about BigBear.A...
Agora's API-driven platform powers live video, voice, and real-time engagement for apps worldwide. This deep dive exa...
When a high-growth fintech faces headwinds, patient investors look for generational buying opportunities. This guide ...
Gary Keller argues that a data-driven view can outweigh market gloom, foreseeing 4.3 million home sales in 2026 and a...